Optimising Diagnostics For Precision Medicine

Transforming diagnostic standards and drug development for
Nonalcoholic Steatohepatitis (NASH) with AI-based digital pathology

Who We Are

Founder of an AI-based digital pathology solution that
aids NASH clinical trials towards optimal outcomes

Bridging Research and Drug Discovery

Working hand-in-hand with our collaborators to accelerate clinical research
and drug development efforts with unrivalled accuracy and sensitivity

NASH Highlights

Catch up on the latest medical advancements and research discoveries on Nonalcoholic Steatohepatitis (NASH) taking place across the globe.

About Us

We are committed towards enhancing the diagnosis of chronic liver conditions like nonalcoholic steatohepatitis (NASH), and accelerating the development of effective treatments.

Find Out More

Game-Changing Solutions

Revolutionizing tissue assessment with Second Harmonic Generation (SHG) and Two-Photon Excitation (TPE) to provide quantitative, objective and accurate data.

Find Out More

qFibrosis

Find Out More

qFIBS

Find Out More

Our Achievements

We have been recognised with several industry-renowned awards for our efforts and accomplishments in the core areas of our business, particularly medical technology and product innovation.

Find Out More

Partnership Opportunities

We are committed towards building strong and mutually rewarding partnerships with world-renowned medical, academic and research institutions as well as market leaders in the Life Sciences and Healthcare sectors.

Publications & Presentations

Follow up on the journal publications and presentations by HistoIndex and our partners that have graced the platforms of globally renowned industry conferences.

NASH Highlights

Bringing our visitors a compilation of news stories and videos, covering the latest developments in NASH across the globe.

News Room

23 Dec 2018

HistoIndex's Second Harmonic Generation (SHG) Technology: A Potentially Important Tool Used In Madrigal's Phase 2 Nonalcoholic Steatohepatitis (NASH) Clinical Trial

06 Jul 2018

HistoIndex Welcomes its New CEO on Board!

08 Jun 2018

A Worldwide Effort to Defeat Nonalcoholic Steatohepatitis (NASH)

EVENTS

Sharing our discoveries and seeking collaborative opportunities.

Find Out More

Talk To Us

Our team will be happy to answer your queries

Enquiry Form

Connect with us on LinkedIn